Core Viewpoint - The article discusses the recent trading activity of the Hong Kong Stock Connect Innovative Drug ETF, highlighting its financing buy-in and net selling figures over a specific period [1]. Group 1: Financing Activity - On August 14, the Hong Kong Stock Connect Innovative Drug ETF received a financing buy-in of 0.37 billion, ranking 1133rd in the market [1]. - The financing repayment amount on the same day was 0.48 billion, resulting in a net sell of 11.85 million [1]. - Over the last three trading days (August 12-14), the ETF saw financing buy-ins of 0.12 billion, 0.13 billion, and 0.37 billion respectively [1]. Group 2: Short Selling Activity - On August 14, there were no shares sold short, resulting in a net short sell of 0.00 shares [1].
港股通创新药ETF工银获融资买入0.37亿元，近三日累计买入0.62亿元
Jin Rong Jie·2025-08-15 01:14